Adicet Bio, Inc. (ACET) vs Heron Therapeutics, Inc. (HRTX)
A side-by-side comparison of Adicet Bio, Inc. and Heron Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACET
Adicet Bio, Inc.
$6.51HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 12:38 PM EDT
Total return — ACET vs HRTX
growth of $100 · dividends reinvested · last 9yACET -99.7% (-46.8%/yr)HRTX -98.5% (-37.1%/yr)HRTX compounded faster over this window
ACET HRTX
ACET vs HRTX: by the numbers
- •HRTX is the larger company ($64M vs $61M market cap).
- •Both run net losses; ACET's is the smaller (0.00% vs -22.52% net margin).
Metrics side by side
Valuation
| Metric | ACET | HRTX |
|---|---|---|
| P/S ratio | N/A | 0.42 |
| P/B ratio | 0.51 | 10.91 |
Profitability
| Metric | ACET | HRTX |
|---|---|---|
| Gross margin | 0.00% | 70.07% |
| Operating margin | 0.00% | -7.19% |
| Net margin | 0.00% | -22.52% |
| ROE | -82.38% | -492.89% |
| ROIC | -79.68% | -6.79% |
Growth (annualized)
| Metric | ACET | HRTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.73% |
| Total return CAGR (5Y) | -44.24% | -48.61% |
Frequently asked
- How have ACET and HRTX total returns compared?
- Over the past 5 years, ACET delivered -44.24% and HRTX delivered -48.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.